Abstract
摘要
相似文献
1
Premarketing trials: too few patients.
Prescrire Int. 2014 Oct;23(153):251.
2
Regulating clinical trials in Europe.
Lancet Oncol. 2013 May;14(6):453-4. doi: 10.1016/S1470-2045(13)70071-8. Epub 2013 Mar 21.
3
[The role of the Danish Medical Products Agency in clinical trials].[丹麦药品管理局在临床试验中的作用]
Ugeskr Laeger. 2003 Apr 14;165(16):1653-6.
4
[The 12th German Drug Law (AMG) amendment: an obstruction for non-commercial clinical trials?].[德国第12次药品法（AMG）修订案：对非商业性临床试验的阻碍？]
Dtsch Med Wochenschr. 2007 Jan 19;132(3):108-12. doi: 10.1055/s-2007-959298.
5
[From molecule to medicine--drug development].从分子到药物——药物研发
Dtsch Med Wochenschr. 2010 Feb;135(6):p5. doi: 10.1055/s-0030-1247669. Epub 2010 Feb 11.
6
[New anticoagulants. A warning shot!].[新型抗凝剂。一次警示！]
Rev Prat. 2013 Feb;63(2):151.
7
Rent increase hits Europe's drug regulator before Brexit move.在英国脱欧行动之前，房租上涨对欧洲药品监管机构造成冲击。
Nature. 2018 Apr;556(7702):418. doi: 10.1038/d41586-018-04917-4.
8
[HTA-Perspective: Challenges in the early assessment of new oncological drugs].[卫生技术评估视角：新型肿瘤药物早期评估中的挑战]
Z Evid Fortbild Qual Gesundhwes. 2013;107(2):129-35. doi: 10.1016/j.zefq.2013.02.008. Epub 2013 Mar 27.
9
Causality Assessment in Premarketing Drug Clinical Trials: Regulatory Evolution in the USA and Ongoing Concerns.上市前药物临床试验中的因果关系评估：美国的监管演变及持续关注的问题
Drug Saf. 2016 Oct;39(10):895-901. doi: 10.1007/s40264-016-0442-9.
10
Preclinical predictors of clinical safety: opportunities for improvement.临床安全性的临床前预测指标：改进的机会。
Clin Pharmacol Ther. 2007 Aug;82(2):210-4. doi: 10.1038/sj.clpt.6100243. Epub 2007 May 16.
Zotero 插件